Correlation Between Revelation Biosciences and PolyPid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and PolyPid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and PolyPid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and PolyPid, you can compare the effects of market volatilities on Revelation Biosciences and PolyPid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of PolyPid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and PolyPid.

Diversification Opportunities for Revelation Biosciences and PolyPid

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Revelation and PolyPid is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and PolyPid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PolyPid and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with PolyPid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PolyPid has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and PolyPid go up and down completely randomly.

Pair Corralation between Revelation Biosciences and PolyPid

Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the PolyPid. In addition to that, Revelation Biosciences is 1.49 times more volatile than PolyPid. It trades about -0.07 of its total potential returns per unit of risk. PolyPid is currently generating about 0.01 per unit of volatility. If you would invest  355.00  in PolyPid on August 31, 2024 and sell it today you would lose (9.00) from holding PolyPid or give up 2.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Revelation Biosciences  vs.  PolyPid

 Performance 
       Timeline  
Revelation Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
PolyPid 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PolyPid has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, PolyPid is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Revelation Biosciences and PolyPid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revelation Biosciences and PolyPid

The main advantage of trading using opposite Revelation Biosciences and PolyPid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, PolyPid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPid will offset losses from the drop in PolyPid's long position.
The idea behind Revelation Biosciences and PolyPid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine